| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/11/2015 | CN101641373B Dkk-1的特异性抗体 Dkk-1 specific antibody of |
| 02/11/2015 | CN101563362B 重组hcv e2糖蛋白 Recombinant glycoproteins hcv e2 |
| 02/10/2015 | US8952144 Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV |
| 02/10/2015 | US8952135 S. agalactiae antigens I and II |
| 02/10/2015 | US8952134 Hybrid constant regions |
| 02/10/2015 | US8952128 Somatostatin-dopamine chimeric analogs |
| 02/10/2015 | US8951975 ECT2 peptides and vaccines including the same |
| 02/10/2015 | US8951972 FGFR1 extracellular domain combination therapies for lung cancer |
| 02/10/2015 | US8951755 Products comprising inactivated yeasts or moulds and active VHH-type antibodies |
| 02/10/2015 | US8951747 Method for modulating activity of T lymphocytes |
| 02/10/2015 | US8951745 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt |
| 02/10/2015 | US8951744 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/10/2015 | US8951737 Treatment and diagnosis of cancer |
| 02/10/2015 | US8951572 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts |
| 02/10/2015 | US8951561 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP) |
| 02/10/2015 | US8951542 Lipid vesicle compositions and methods of use |
| 02/10/2015 | US8951538 Exopolysaccharide of Shigella sonnei bacteria, method for producing same, vaccine and phamaceutical composition containing same |
| 02/10/2015 | US8951537 Functional influenza virus-like particles (VLPs) |
| 02/10/2015 | US8951535 Lentiviral vectors containing an MHC class I promoter |
| 02/10/2015 | US8951534 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus |
| 02/10/2015 | US8951532 A25 bacteriophage lysin |
| 02/10/2015 | US8951531 Modified Streptococcus pneumonia pneumolysin (PLY) polypeptides |
| 02/10/2015 | US8951530 Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies |
| 02/10/2015 | US8951528 Immune response modifier conjugates |
| 02/10/2015 | US8951527 Radioprotectants targeting thrombospondin-1 and CD47 |
| 02/10/2015 | US8951525 Human tissue factor antibody and uses thereof |
| 02/10/2015 | US8951524 Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for treatment of certain cancers |
| 02/10/2015 | US8951523 Targeting rare human PCSK9 variants for cholesterol treatment |
| 02/10/2015 | US8951522 Methods for treating conditions associated with MASP-2 dependent complement activation |
| 02/10/2015 | US8951521 Compounds having activity of suppressing activation of TGF-β receptor, method for screening of the compounds, and composition for preventing or treating disease caused by hepatitis C virus |
| 02/10/2015 | US8951519 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/10/2015 | US8951518 Substance specific to human PD-1 |
| 02/10/2015 | US8951517 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 02/10/2015 | US8951516 Variant immunoglobulins with improved manufacturability |
| 02/10/2015 | CA2734654C An immunological composition comprising sulpholipo-cyclodextrin and saponin |
| 02/10/2015 | CA2600350C Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 02/10/2015 | CA2537473C Cytokine involved in epithelial-mesenchymal transition |
| 02/10/2015 | CA2489860C Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions |
| 02/05/2015 | WO2015017823A1 Tetravalent pneumococcal serogroup 6z |
| 02/05/2015 | WO2015017822A1 Antibodies or fusion proteins multimerized via homomultimerizing peptide |
| 02/05/2015 | WO2015017817A1 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof |
| 02/05/2015 | WO2015017690A1 Treatment of multiple sclerosis by alemtuzumab induction followed by laquinimod therapy |
| 02/05/2015 | WO2015017683A1 Antimicrobial compositions and methods of use |
| 02/05/2015 | WO2015017673A1 Methods for producing influenza vaccine compositions |
| 02/05/2015 | WO2015017600A1 Afucosylated anti-fgfr2iiib antibodies |
| 02/05/2015 | WO2015017576A1 Anti-activin a antibodies and uses thereof |
| 02/05/2015 | WO2015017548A2 Stabilization of fc-containing polypeptides |
| 02/05/2015 | WO2015017280A1 Vaccine formulations that induce a th2 immune response |
| 02/05/2015 | WO2015017214A1 Multipartite signaling proteins and uses thereof |
| 02/05/2015 | WO2015017132A1 Methods of reducing salmonella in poultry |
| 02/05/2015 | WO2015017113A2 Tumor selective antibodies specific to oncofetal antigen / immature laminin receptor protein |
| 02/05/2015 | WO2015016718A1 Combining cd27 agonists and immune checkpoint inhibition for immune stimulation |
| 02/05/2015 | WO2015016559A1 Anti-egfr antibody and anti-c-met/anti-egfr bispecific antibodies comprising the same |
| 02/05/2015 | WO2015016386A1 Medicament comprising anti-phospholipase d4 antibody |
| 02/05/2015 | WO2015016354A1 Liposomes and vaccine composition for inducing cytotoxic t cell activity |
| 02/05/2015 | WO2015016282A1 Pharmaceutical composition for preventing or treating radiation-induced gastrointestinal syndrome |
| 02/05/2015 | WO2015015818A1 Composition for ameliorating metabolic disorders caused by diabetes |
| 02/05/2015 | WO2015015654A1 Corneal endothelium ecm therapeutic drug |
| 02/05/2015 | WO2015015490A1 Trophoblast derived microparticles for treating ischemic tissue and wounds |
| 02/05/2015 | WO2015015033A1 Bioencapsulation of the probiotic shewanella putrefaciens pdp11 in living food and uses |
| 02/05/2015 | WO2015015003A1 Anti-garp protein and uses thereof |
| 02/05/2015 | WO2015014870A1 Diagnosis and therapy of cancer involving cancer stem cells |
| 02/05/2015 | WO2015014869A1 Tumor antigens for determining cancer therapy |
| 02/05/2015 | WO2015014820A1 Prostate cancer immunotherapy |
| 02/05/2015 | WO2015014659A1 Anti-claudin 1 antibodies and uses thereof |
| 02/05/2015 | WO2015014657A1 Anti-claudin 1 antibodies for use in the treatment of colorectal cancer |
| 02/05/2015 | WO2015014487A1 Process for preparing a highly pure neurotoxic component of a botulinum toxin and uses thereof |
| 02/05/2015 | WO2015014376A1 Diagnosis and therapy of cancer involving cancer stem cells |
| 02/05/2015 | WO2015014375A1 Tumor antigens for determining cancer therapy |
| 02/05/2015 | WO2015014327A1 Divalent vaccine compositions and the use thereof for treating tumours |
| 02/05/2015 | WO2015013739A1 Attenuated babesia vaccine |
| 02/05/2015 | WO2014190441A9 Heteromultimers with reduced or silenced effector function |
| 02/05/2015 | US20150040251 Sheep nematode vaccine |
| 02/05/2015 | US20150038685 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 02/05/2015 | US20150037374 Anti-tumor compositions and uses thereof |
| 02/05/2015 | US20150037373 Method of enhancing the proliferative phase of a primary t cell response |
| 02/05/2015 | US20150037372 pH-Responsive High-Density Lipoprotein-Like Particle Complex |
| 02/05/2015 | US20150037371 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
| 02/05/2015 | US20150037370 Diatom-based vaccines |
| 02/05/2015 | US20150037369 Methods of Transforming a Listeria |
| 02/05/2015 | US20150037368 Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines |
| 02/05/2015 | US20150037367 Methods and Compositions Of Protein Antigens For The Diagnosis And Treatment of Herpes Simplex Viruses Type 1 and 2 |
| 02/05/2015 | US20150037366 Method for treating inflammation |
| 02/05/2015 | US20150037365 Novel malaria vaccine |
| 02/05/2015 | US20150037363 Recombinant t-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction |
| 02/05/2015 | US20150037361 Compositions and methods to treat the bihormonal disorder in diabetes |
| 02/05/2015 | US20150037357 Immune stimulation/metabolic inhibition as antitumor therapy |
| 02/05/2015 | US20150037355 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
| 02/05/2015 | US20150037354 Combination therapies including inhibitors of the extracellular domain of e-cadherin |
| 02/05/2015 | US20150037352 Novel ha binding agents |
| 02/05/2015 | US20150037351 Novel therapeutic target for the prevention of tumour metastasis |
| 02/05/2015 | US20150037350 Negative modulator of hedgehog signalling for use in treating th2-mediated diseases |
| 02/05/2015 | US20150037347 Method of treating a pathological syndrome and a pharmaceutical agent |
| 02/05/2015 | US20150037338 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders |
| 02/05/2015 | US20150037336 Combination of hb-egf binding protein and egfr inhibitor |
| 02/05/2015 | US20150037333 Tumour necrosis factor receptor fusion proteins and methods of using the same |
| 02/05/2015 | US20150037332 Treatment of metastic breast cancer |
| 02/05/2015 | US20150037329 Method of reducing titers of antibodies specific for a therapeutic agent |
| 02/05/2015 | US20150037326 Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen |
| 02/05/2015 | US20150037325 Slit-robo signaling for diagnosis and treatment of kidney disease |